Date post: | 14-Apr-2018 |
Category: |
Documents |
Upload: | teus-fatamorgana |
View: | 218 times |
Download: | 0 times |
of 49
7/30/2019 Pharmacology of Drugs for Anemia
1/49
PHARMACOLOGY OF DRUGS FOR
ANEMIA
Dr.Datten Bangun MSc.SpFK
Dept.Farmakologi & TherapetikFak.Kedokteran UHN
M E D A N
7/30/2019 Pharmacology of Drugs for Anemia
2/49
ANEMIA
Anemia can be defined as a reduction in the
hemoglobin,hematocrit or red cell number.
In physiologic terms an anemia is any disorder
in which the patient suffers from tissue
hypoxia due to decreased oxygen carryingcapacity of the blood
7/30/2019 Pharmacology of Drugs for Anemia
3/49
Hematinics
These are drugs used to treat anemia
IronVitamin B12, Cyanocobalamin
Folic acid
Erythropoietin
7/30/2019 Pharmacology of Drugs for Anemia
4/49
4
TYPES OF ANEMIA
Various classifications:Examples:
Iron deficiency anemia ----
microcytic , hypochromicMegaloblastic anemia ----
macrocytic , normochromic
due to Vit. B12 or Folic Acid deficiency
Anemia due to decreased Erythropoietin
as in chronic renal failure
7/30/2019 Pharmacology of Drugs for Anemia
5/49
Causes of Anemia
1. Diminished production and or
replacement of red blood cells.
2. Excessive breakdown and loss of red
blood cells.
Hemodilution while not a cause of anemia, it
does cause an anemia-like effect.
7/30/2019 Pharmacology of Drugs for Anemia
6/49
1. Diminished Production/Replacement of
RBCs Anemia's
Microcytic anemia deficiency of Fe RBCs appear pale and smaller, and we see more reticulocytes
in circulation.
Can be caused by the chronic use of aspirin, which irritatesthe stomach GI blood loss.
Normocytic anemia deficiency of Erythropoietin Caused by compromised renal function.
Macrocytic Anemia- deficiency of folic acid and B12 Diminished cell division and release of larger cells in
circulation.
7/30/2019 Pharmacology of Drugs for Anemia
7/49
2. Breakdown of RBCs Anemia
Bleeding: can be due to an ulcer or in females bloodloss due to their menstrual cycle
Use of drugs that irritate the GI tract (aspirin)
Hemolysis (Hemolytic Anemia) can be caused by:
Autoimmune disease
Mechanical (heart valves, microvascular disease)
Toxins (e.g., snake venom)
7/30/2019 Pharmacology of Drugs for Anemia
8/49
Anti anaemic Drugs
Haematopoiesis: it is the production of
erythrocytes, platelets, and leukocytes from
undifferentiated stem cells.
The haematopoietic machinary reside in the
bone marrow in adults.
It requires a constant supply of essential
nutrients iron, vit B12, folic acid and
presence of hematopoietic growth factors
7/30/2019 Pharmacology of Drugs for Anemia
9/49
9
ANTI-ANEMIC DRUGS
Drugs effective in iron deficiency and otherhypochromic anemias:
Iron
Pyridoxine , Riboflavin , CopperDrugs effective in megaloblastic anemia:
Vitamin B12
Folic Acid
Hematopoietic growth factors:
Erythropoietin
7/30/2019 Pharmacology of Drugs for Anemia
10/49
IRON FACTS
All body cells need iron. It is crucial for oxygen
transport, energy production, and cellular growth
and proliferation.
The human body contains an average of 3.5 g of
iron (males 4 g, females 3 g).
The typical daily normal diet contains 10
20 mg ofiron.
Only about 10% of dietary iron is absorbed (12 mg/day).
7/30/2019 Pharmacology of Drugs for Anemia
11/49
Anti anaemic Drugs
Iron: Total quantity of iron in the body is 4-5G,
65-70% in the form of Hb in RBC, 4% in
myoglobin, 1% in various heme compound,
15-30% stored in the form of ferritin and
hemosiderin in RE system, liver, spleen,
intestinal mucosa and bone marrow
7/30/2019 Pharmacology of Drugs for Anemia
12/49
12
IRON
Preparations:Oral:
Ferrous sulphate
Ferrous gluconateFerrous fumarate , etc.
Parenteral:
Iron dextran ---- i.m or i.v
Iron Sorbitol ----- i.m only.
7/30/2019 Pharmacology of Drugs for Anemia
13/49
13
Pharmacokinetics
Absorption ---- depends on
requirements
iron stores
Ferrous (Fe++) / ferric (Fe+++) form
pH
Vitamin C Chelators or complexing agents
Malabsorption syndrome
7/30/2019 Pharmacology of Drugs for Anemia
14/49
Iron transport
Most absorbed iron is transported in thebloodstream bound to the glycoprotein
transferrin.
Transferrin is a carrier protein that plays a
role in regulating the transport of iron from
the site of absorption to virtually all tissues.
Transferrin binds only two iron atoms.
Normally, 2045% of transferrin binding sites
are filled (measured as percent transferrin
saturation [TS]).
7/30/2019 Pharmacology of Drugs for Anemia
15/49
Iron transport
7/30/2019 Pharmacology of Drugs for Anemia
16/49
Ferritin molecules storethousands of iron atoms
within their mineral core.
When excess dietary iron is
absorbed, the body
responds by producing
more ferritin to facilitate
iron storage.
7/30/2019 Pharmacology of Drugs for Anemia
17/49
Importance of Iron
Iron forms the nucleus of the iron-porphyrin heme ring,
This with globin chains forms hemoglobin.
Function of Haemoglobin:
Reversibly binds oxygen and provides the critical
Mechanism for oxygen delivery from the lungs to other
tissues.
In the absence of adequate iron, small erythrocytes
with insufficient hemoglobin are formed, giving rise to
Microcytic hypochromic anemia
7/30/2019 Pharmacology of Drugs for Anemia
18/49
18
Acute Oral toxicity (overdose ; poisoning)
Necrotizing gastroenteritis with ----
vomiting, abdominal pain, bloody diarrhea
Shock , lethargy & dyspnea
Severe metabolic acidosis
Coma
Death
A O l i i ( d i i )
7/30/2019 Pharmacology of Drugs for Anemia
19/49
19
Acute Oral toxicity (overdose ; poisoning):
(Contd.)
Treatment:Whole bowel irrigation
Desferrioxamine (Deferoxamine)
orally --- for Unabsorbed iron Parenteral ( i.m. , i.v. ) --- for iron absorbed
Desferrioxamine + ferric iron
Ferrioxamine --- excreted in urine and bile.
7/30/2019 Pharmacology of Drugs for Anemia
20/49
20
Chronic iron toxicity (iron overload): (Contd.)
Hemosiderosis:
a focal or general increase in tissue iron stores
without associated tissue damage
Hemochromatosis:
associated with tissue damage
h i i i i (i l d)
7/30/2019 Pharmacology of Drugs for Anemia
21/49
21
Chronic iron toxicity (iron overload)
(Contd.)
Treatment:
IntermittentVenesection(Phlebotomy)----
when there is no anemia
Chelation (Desferrioxamine) ----
for transfusional overload
7/30/2019 Pharmacology of Drugs for Anemia
22/49
22
Adverse effects of Parenteral iron therapy
Local pain & tissue staining
(browndiscoloration of tissue overlying the injection
site).
Headache , light-headedness , fever , arthralgias,
nausea , vomiting , back pain , flushing ,
urticaria, bronchospasm , & ,
Rarely anaphylaxis & death
7/30/2019 Pharmacology of Drugs for Anemia
23/49
23
VITAMIN B12
Chemistry
Porphyrin-like ring with a central cobalt atom
& nucleotide.
Cobalamins = various organic groups covalentlybound to cobalt atom
Cyanocobalamine hydroxycobalamin & other
cobalamins (found in food sources) are convertedto active forms Deoxyadenosylcobalamin
&methylcobalamin
7/30/2019 Pharmacology of Drugs for Anemia
24/49
24
Active forms of vitamin B12 in human:
Deoxyadenosylcobalamin
Methylcobalamin
Vitamin B12 available for therapeutic uses:
Cyanocobalamin
Hydroxycobalamin
Hydroxycobalamin --- is preferred becauseit is highly protein-bound & therefore
remains longer in the circulation.
Ph ki ti
7/30/2019 Pharmacology of Drugs for Anemia
25/49
25
Pharmacokinetics
Absorption:
Intrinsic factor (IF) --- a glycoprotein ,secreted by parietal cells of gastric mucosa
IF-Vit.B12 Complex --- absorbed by
active transport in the distal ileum
Transported in plasma bound to the
glycoprotein transcobalamin II &
is taken up by tissues where required &
stored in hepatocytes
Pharmacokinetics (Contd )
7/30/2019 Pharmacology of Drugs for Anemia
26/49
26
Pharmacokinetics (Contd.)
Route of administration
Mostly ------ Parenteral ---- i.m.
Oral
Aerosol
Pharmacokinetics (Contd )
7/30/2019 Pharmacology of Drugs for Anemia
27/49
27
Pharmacokinetics (Contd.)
Elimination:
not significantly metabolized
pass into bile
Enterohepatic circulation
Excreted via kidney
Features of Vitamin B12 deficiency
7/30/2019 Pharmacology of Drugs for Anemia
28/49
28
Features of Vitamin B12 deficiency
Impairment of DNA synthesis
affects all cells but most apparently RBCs.
Megaloblastic Anemia
GI symptoms
neurologic abnormalities
7/30/2019 Pharmacology of Drugs for Anemia
29/49
29
Features Vitamin B12 deficiency (Contd.)
Neurological abnormalities :
Degeneration of brain and spinal cord (Subacute
combined degeneration ) and peripheral nerves.
Symptoms may be psychiatric & physical.Paresthesia & weakness in peripheral nerves
spasticity, ataxia, & other CNS dysfunction
7/30/2019 Pharmacology of Drugs for Anemia
30/49
30
Uses
Pernicious (addisonian) anemia
After partial or total gastrectomy
Malabsorption syndromes
Insufficient dietary intake
Hydroxycobalamin (Not cyanocobalamin)
Tobacco Amblyopia
Cyanide toxicity
d ff
7/30/2019 Pharmacology of Drugs for Anemia
31/49
31
Adverse effects
Allergic hypersensitivity reactionsAntibodies to hydroxycobalamin-transcobalamin
II complex
Arrhythmias secondary to hypokalemia
7/30/2019 Pharmacology of Drugs for Anemia
32/49
32
FOLIC ACID (PTEROYLGLUTAMIC ACID; VITAMIN B9)
Is inactive Active form is ---- tetrahydrofolic acid
7/30/2019 Pharmacology of Drugs for Anemia
33/49
33
Pharmacokinetics
Route of administration ----- usually oral
In diet ---- Polyglutamate form
For absorption ---- must be converted to ---Mono-glutamyl form
Absorbed mostly --- in proximal jejunum
7/30/2019 Pharmacology of Drugs for Anemia
34/49
34
Functions
Is required for synthesis of Amino acids ,
purines, pyrimidines, & DNA ; &
therefore in the cell division
7/30/2019 Pharmacology of Drugs for Anemia
35/49
35
Features of folic acid deficiency
Mitotically active tissues such as
erythroid tissues are markedly affected.
Anemia
Congenital malformations ---
neural tube defects ( e.g., spina bifida)
Vascular disease
7/30/2019 Pharmacology of Drugs for Anemia
36/49
36
Vitamin C
Vitamin C deficiency can cause megaloblastic anemia
7/30/2019 Pharmacology of Drugs for Anemia
37/49
37
Uses
Prevention & treatment of folic acid deficiency
Dietary insufficiency (e.g. in elderly)
Pregnancy & lactation
to prevent --- Congenital malformations ---neural tube defects ( e.g., spina bifida)
High red cell turn over --- e.g. in
hemolytic anemias ---
Premature infants
Malabsorption syndromes
Uses (contd )
7/30/2019 Pharmacology of Drugs for Anemia
38/49
38
Uses (contd.)
Drugs
Antiepileptics ---- enzyme inducers
Phenytoin
Primidone
Phenobarbitone
Antimalarials
pyrimethamine
Methotrexate
FOLINIC ACID (not folic acid)
7/30/2019 Pharmacology of Drugs for Anemia
39/49
39
Uses (contd.)
Myelofibrosis
Exfoliative dermatitis
Rheumatoid arthritis
Malignant disease , e.g., lymphoma Chronic hemodialysis
7/30/2019 Pharmacology of Drugs for Anemia
40/49
40
Adverse effects
Generally well tolerated
Rarely ---
G.I. Disturbances
hypersensitivity reactions Status epilepticus may be precipitated
7/30/2019 Pharmacology of Drugs for Anemia
41/49
41
ERYTHROPOIETIN (EPOTEIN)
a glycoprotein hormone
produced :
90% --- by peritubular cells in kidney
remainder --- by liver and other tissues is essential for normal reticulocyte production
synthesis is stimulated by hypoxia
synthesized for clinical use ---- by ---
recombinant DNA technology
7/30/2019 Pharmacology of Drugs for Anemia
42/49
42
Pharmacokinetics
Route of administration --- S.C. or I.V.
Plasma t1/2 ---- 4 - 13 hrs in patients with
chronic renal failure.
Not cleared by dialysis
7/30/2019 Pharmacology of Drugs for Anemia
43/49
43
Mechanism of action
increases rate of stem cell differentiation
increases rate ofmitosis in red cell precursors,
blast-forming units, colony forming cells.
increases release ofreticulocyte from marrowincreases Hb synthesis
its action requires adequate stores ofiron
Uses
7/30/2019 Pharmacology of Drugs for Anemia
44/49
44
Uses
Anemia associated with chronic renal failure
premature infantsAnemia during chemotherapy ofcancer
Anemia ofAIDS (which is exacerbated by
zidovudine treatment)
to increase the yield ofautologous blood before
donation
Anemia of chronic inflammatory conditions
such as rheumatoid arthritis
MISUSED --- by sports people
7/30/2019 Pharmacology of Drugs for Anemia
45/49
45
Adverse effects
Usually due to excessive increase in hematocrit
increase blood pressure
thrombosis
seizures
headache
hypertensive crises with encephalopathy-like
symptoms
clotting in dialyser
7/30/2019 Pharmacology of Drugs for Anemia
46/49
46
Adverse effects
Transient influenza-like symptoms ------
chills & myalgias
iron deficiency
transient increases in platelet count
hyperkalemia
skin rashes
pure red cell aplasia --- discontinue the drug
antibodies to epoetins
/ d
7/30/2019 Pharmacology of Drugs for Anemia
47/49
47
Precautions / contraindications
hypertension should be well controlled
seizures
thrombocytosis
ischemic vascular disease
iron , folic acid , vit. B12 supplements may be
needed
heparin during dialysis
i
7/30/2019 Pharmacology of Drugs for Anemia
48/49
48
Monitor
hematocrit
blood pressure
platelet count
serum potassium
7/30/2019 Pharmacology of Drugs for Anemia
49/49